Patents
US 8513242 B2: Pyrimidine compounds and methods of making and using same
- Granted
- 2013-08-20
- Filed
- 2009-12-11 application 13139009
- Type
- Utility · 13 claims
- Elsewhere
- Google Patents ↗ · USPTO patent document ↗ · USPTO Patent Center record ↗
Abstract
Disclosed herein are pyrimidinyl compounds that are contemplated to be modulators of cystic fibrosis transmembrane regulators (CFTR), and methods of making and using same. Also provided are pharmaceutical compositions and methods of treating disorders associated with cystic fibrosis transmembrane regulators, such as airway inflammation, cystic fibrosis, and the like.
Source: PVGPATDIS, file of 2026-04-10 (ipg130820.xml).
Assignees
| Assignee | Type | Place | Also on furp.org | Source |
|---|---|---|---|---|
| CYSTIC FIBROSIS FOUNDATION THERAPEUTICS, INC. 5 patents | US company or organization | Bethesda, MD | CYSTIC FIBROSIS FOUNDATION THERAPEUTICS INC Nonprofit EXACT high confidence: identical full name and state | PVGPATDIS, file of 2026-04-10 |
Inventors
| Inventor | Place | Patents | Person page | Source |
|---|---|---|---|---|
| Phoebe Chiang | East Lyme, CT | 2 | PVGPATDIS, file of 2026-04-10 | |
| Shomir Ghosh | Brookline, MA | 64 | PVGPATDIS, file of 2026-04-10 |
CPC categories
| Subclass | Category | First group | Source |
|---|---|---|---|
| C07D | Heterocyclic compounds | C07D403/14 | PVGPATDIS, file of 2026-04-10 |
| A61P | Specific therapeutic activity of chemical compounds or medicinal preparations | A61P3/00 | PVGPATDIS, file of 2026-04-10 |
Cooperative Patent Classification, as currently assigned (one row per subclass).
Assignments and security interests
| Recorded | What | From | To | Reel/frame | Source |
|---|---|---|---|---|---|
| 2019-12-11 | Correction Corrective assignment to correct the correct execution date previously recorded at reel: 049311 frame: 0713. assignor(s) hereby confirms the assignment. | CYSTIC FIBROSIS FOUNDATION THERAPEUTICS, INC. signed 2019-05-29 | CYSTIC FIBROSIS FOUNDATION BETHESDA, MD | 51256/161 | PASDL, file of 2026-10-15 |
| 2019-05-29 | Assignment Assignment of assignor's interest | CYSTIC FIBROSIS FOUNDATION THERAPEUTICS, INC. signed 2019-05-26 | CYSTIC FIBROSIS FOUNDATION BETHESDA, MD | 49311/713 | PASDL, file of 2026-10-15 |
Documents recorded with the USPTO Assignment Recordation Branch that list this patent. A security interest is a lender’s claim on the patent as collateral; a release ends it.
USPTO bulk data: PatentsView granted patents, disambiguated (PVGPATDIS) for patents, assignees, inventors, places and CPC categories; the USPTO Patent Assignment Dataset (ECORSEXC) for assignments and security interests. Patents filed in the last 20 years. No claims or full text. Links to other records are by name (and state): EXACT means the identical full name and state; FUZZY means a looser name match, with the confidence shown.